4.6 Article

The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 284, 期 38, 页码 25560-25568

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M109.007690

关键词

-

资金

  1. National Institutes of Health [HL007781, CA101690, CA112775]
  2. American Heart Association [0725942Z]
  3. Fanconi Anemia Research Fund

向作者/读者索取更多资源

Genomic stability requires a functional Fanconi anemia (FA) pathway composed of an upstream core complex (FA proteins A/B/C/E/F/G/L/M) that mediates monoubiquitination of the downstream targets FANCD2 and FANCI. Unique among FA core complex members, FANCM has processing activities toward replication-associated DNA structures, suggesting a vital role for FANCM during replication. Using Xenopus egg extracts, we analyzed the functions of FANCM in replication and the DNA damage response. xFANCM binds chromatin in a replication-dependent manner and is phosphorylated in response to DNA damage structures. Chromatin binding and DNA damage-induced phosphorylation of xFANCM are mediated in part by the downstream FA pathway protein FANCD2. Moreover, phosphorylation and chromatin recruitment of FANCM is regulated by two mayor players in the DNA damage response: the cell cycle checkpoint kinases ATR and ATM. Our results indicate that functions of FANCM are controlled by FA- and non-FA pathways in the DNA damage response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Genetics & Heredity

Fanconi anemia proteins stabilize replication forks

Lily Chien Wang, Stacie Stone, Maureen Elizabeth Hoatlin, Jean Gautier

DNA REPAIR (2008)

Article Oncology

A novel cell-free screen identities a potent inhibitor of the Fanconi anemia pathway

Igor Landais, Alexandra Sobeck, Stacie Stone, Alexis LaChapelle, Maurcen E. Hoatlin

INTERNATIONAL JOURNAL OF CANCER (2009)

Article Biochemistry & Molecular Biology

A Histone-Fold Complex and FANCM Form a Conserved DNA-Remodeling Complex to Maintain Genome Stability

Zhijiang Yan, Mathieu Delannoy, Chen Ling, Danielle Daee, Fekret Osman, Parameswary A. Muniandy, Xi Shen, Anneke B. Oostra, Hansen Du, Jurgen Steltenpool, Ti Lin, Beatrice Schuster, Chantal Decaillet, Andrzej Stasiak, Alicja Z. Stasiak, Stacie Stone, Maureen E. Hoatlin, Detlev Schindler, Christopher L. Woodcock, Hans Joenje, Ranjan Sen, Johan P. de Winter, Lei Li, Michael M. Seidman, Matthew C. Whitby, Kyungjae Myung, Angelos Constantinou, Weidong Wang

MOLECULAR CELL (2010)

Review Oncology

Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy

Stacie Ittershagen, Solveig Ericson, Lamis Eldjerou, Ali Shojaee, Eric Bleickardt, Manisha Patel, Tetiana Taran, Oezlem Anak, Charlene Hall, Mimi Leung, Deborah Roccoberton, Florence Salmon, Miriam Fuchs, Vadim Romanov, David Lebwohl

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)

Article Biochemistry & Molecular Biology

Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery

Maya Raghunandan, Jung Eun Yeo, Ryan Walter, Kai Saito, Adam J. Harvey, Stacie Ittershagen, Eun-A Lee, Jihyeon Yang, Maureen E. Hoatlin, Anja K. Bielinsky, Eric A. Hendrickson, Orlando Scharer, Alexandra Sobeck

HUMAN MOLECULAR GENETICS (2020)

Article Medicine, Research & Experimental

Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World

Gentry King, Stacie Ittershagen, Luyang He, Ying Shen, Frank Li, Reginald Villacorta

Summary: This study described real-world treatment patterns and outcomes for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the USA. The study found that most patients received first-line treatment in accordance with clinical practice guidelines, but overall survival remained poor. The study highlights the need for novel therapies to improve patient survival.

ADVANCES IN THERAPY (2022)

Article Cell Biology

Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9

Stacie Stone, Alexandra Sobeck, Margriet van Kogelenberg, Bendert de Graaf, Hans Joenje, Jan Christian, Maureen E. Hoatlin

GENES TO CELLS (2007)

Article Biochemistry & Molecular Biology

DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2

A. Sobeck, S. Stone, M. E. Hoatlin

MOLECULAR AND CELLULAR BIOLOGY (2007)

Article Genetics & Heredity

A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M

AR Meetei, AL Medhurst, C Ling, YT Xue, TR Singh, P Bier, J Steltenpool, S Stone, I Dokal, CG Mathew, M Hoatlin, H Joenje, JP de Winter, WD Wang

NATURE GENETICS (2005)

Article Biochemistry & Molecular Biology

The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific

MS Dai, N Chevallier, S Stone, MC Heinrich, M McConnell, T Reuter, HE Broxmeyer, JD Licht, L Lu, ME Hoatlin

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG

JP de Winter, L van der Weel, J de Groot, S Stone, Q Waisfisz, F Arwert, RJ Scheper, FAE Kruyt, ME Hoatlin, H Joenje

HUMAN MOLECULAR GENETICS (2000)

Article Hematology

Posttranscriptional cell cycle-dependent regulation of human FANCC expression

MC Heinrich, KV Silvey, S Stone, AJ Zigler, DJ Griffith, M Montalto, L Chai, Y Zhi, ME Hoatlin

Review Biochemistry & Molecular Biology

Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks

A Sobeck, S Stone, V Costanzo, B de Graaf, T Reuter, J de Winter, M Wallisch, Y Akkari, S Olson, WD Wang, H Joenje, JL Christian, PJ Lupardus, KA Cimprich, J Gautier, ME Hoatlin

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Cell Biology

Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg

HJ van de Vrugt, M Koomen, MAD Berns, Y de Vries, MA Rooimans, L van der Weel, E Blom, J de Groot, RJ Schepers, S Stone, ME Hoatlin, NC Cheng, H Joenje, F Arwert

GENES TO CELLS (2002)

暂无数据